{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T02:05:04Z","timestamp":1793239504539,"version":"4.5.0"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,6,26]],"date-time":"2018-06-26T00:00:00Z","timestamp":1529971200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,6,26]],"date-time":"2018-06-26T00:00:00Z","timestamp":1529971200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    The mechanisms that connect complement system activation and basal deposit formation in early stages of age-related macular degeneration (AMD) are insufficiently understood, which complicates the design of efficient therapies to prevent disease progression. Using human fetal (hf) retinal pigment epithelial (RPE) cells, we have established an\n                    <jats:italic>in vitro<\/jats:italic>\n                    model to investigate the effect of complement C3a on RPE cells and its role in the formation of sub-RPE deposits. The results of these studies revealed that C3a produced after C3 activation is sufficient to induce the formation of sub-RPE deposits via complement-driven proteasome inhibition. C3a binds the C3a receptor (C3aR), stimulates deposition of collagens IV and VI underneath the RPE, and impairs the extracellular matrix (ECM) turnover by increased MMP-2 activity, all mediated by downregulation of the ubiquitin proteasome pathway (UPP). The formation of basal deposits can be prevented by the addition of a C3aR antagonist, which restores the UPP activity and ECM turnover. These findings indicate that the cell-based model can be used to test potential therapeutic agents\n                    <jats:italic>in vitro<\/jats:italic>\n                    . The data suggest that modulation of C3aR-mediated events could be a therapeutic approach for treatment of early AMD.\n                  <\/jats:p>","DOI":"10.1038\/s41598-018-28143-0","type":"journal-article","created":{"date-parts":[[2018,6,20]],"date-time":"2018-06-20T05:20:38Z","timestamp":1529472038000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":58,"title":["C3a triggers formation of sub-retinal pigment epithelium deposits via the ubiquitin proteasome pathway"],"prefix":"10.1038","volume":"8","author":[{"given":"Rosario","family":"Fernandez-Godino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric A.","family":"Pierce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,6,26]]},"reference":[{"key":"28143_CR1","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1152\/physrev.00021.2004","volume":"85","author":"O Strauss","year":"2005","unstructured":"Strauss, O. The retinal pigment epithelium in visual function. Physiol Rev 85, 845\u2013881, https:\/\/doi.org\/10.1152\/physrev.00021.2004 (2005).","journal-title":"Physiol Rev"},{"key":"28143_CR2","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/978-3-319-17121-0_8","volume":"854","author":"R Fernandez-Godino","year":"2016","unstructured":"Fernandez-Godino, R., Pierce, E. A. & Garland, D. L. Extracellular Matrix Alterations and Deposit Formation in AMD. Adv Exp Med Biol 854, 53\u201358, https:\/\/doi.org\/10.1007\/978-3-319-17121-0_8 (2016).","journal-title":"Adv Exp Med Biol"},{"key":"28143_CR3","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1001\/archopht.1986.01050150124042","volume":"104","author":"JA Bryan 3rd","year":"1986","unstructured":"Bryan, J. A. 3rd. & Campochiaro, P. A. A retinal pigment epithelial cell-derived growth factor(s). Arch Ophthalmol 104, 422\u2013425 (1986).","journal-title":"Arch Ophthalmol"},{"key":"28143_CR4","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/B978-1-4557-0737-9.00020-5","volume":"1","author":"CA Curcio","year":"2013","unstructured":"Curcio, C. A. & Johnson, M. Structure, function, and pathology of Bruch\u2019s membrane. Retina 1, 465\u2013481 (2013).","journal-title":"Retina"},{"key":"28143_CR5","doi-asserted-by":"publisher","first-page":"e2593","DOI":"10.1371\/journal.pone.0002593","volume":"3","author":"HP Scholl","year":"2008","unstructured":"Scholl, H. P. et al. Systemic complement activation in age-related macular degeneration. PLoS One 3, e2593, https:\/\/doi.org\/10.1371\/journal.pone.0002593 (2008).","journal-title":"PLoS One"},{"key":"28143_CR6","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/S0002-9394(02)01624-0","volume":"134","author":"DH Anderson","year":"2002","unstructured":"Anderson, D. H., Mullins, R. F., Hageman, G. S. & Johnson, L. V. A role for local inflammation in the formation of drusen in the aging eye. Am J Ophthalmol 134, 411\u2013431 (2002).","journal-title":"Am J Ophthalmol"},{"key":"28143_CR7","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.preteyeres.2009.11.003","volume":"29","author":"DH Anderson","year":"2010","unstructured":"Anderson, D. H. et al. The pivotal role of the complement system in aging and age-related macular degeneration: hypothesis re-visited. Prog Retin Eye Res 29, 95\u2013112, https:\/\/doi.org\/10.1016\/j.preteyeres.2009.11.003 (2010).","journal-title":"Prog Retin Eye Res"},{"key":"28143_CR8","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/S1350-9462(01)00010-6","volume":"20","author":"GS Hageman","year":"2001","unstructured":"Hageman, G. S. et al. An integrated hypothesis that considers drusen as biomarkers of immune-mediated processes at the RPE-Bruch\u2019s membrane interface in aging and age-related macular degeneration. Prog Retin Eye Res 20, 705\u2013732 (2001).","journal-title":"Prog Retin Eye Res"},{"key":"28143_CR9","doi-asserted-by":"publisher","first-page":"7227","DOI":"10.1073\/pnas.0501536102","volume":"102","author":"GS Hageman","year":"2005","unstructured":"Hageman, G. S. et al. A common haplotype in the complement regulatory gene factor H (HF1\/CFH) predisposes individuals to age-related macular degeneration. Proc Natl Acad Sci USA 102, 7227\u20137232, https:\/\/doi.org\/10.1073\/pnas.0501536102 (2005).","journal-title":"Proc Natl Acad Sci USA"},{"key":"28143_CR10","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1038\/ng.2741","volume":"45","author":"JM Seddon","year":"2013","unstructured":"Seddon, J. M. et al. Rare variants in CFI, C3 and C9 are associated with high risk of advanced age-related macular degeneration. Nat Genet 45, 1366\u20131370, https:\/\/doi.org\/10.1038\/ng.2741 (2013).","journal-title":"Nat Genet"},{"key":"28143_CR11","doi-asserted-by":"publisher","first-page":"3142","DOI":"10.1016\/j.ajpath.2014.07.017","volume":"184","author":"RF Mullins","year":"2014","unstructured":"Mullins, R. F. et al. The membrane attack complex in aging human choriocapillaris: relationship to macular degeneration and choroidal thinning. Am J Pathol 184, 3142\u20133153, https:\/\/doi.org\/10.1016\/j.ajpath.2014.07.017 (2014).","journal-title":"Am J Pathol"},{"key":"28143_CR12","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1006\/exer.1999.0798","volume":"70","author":"LV Johnson","year":"2000","unstructured":"Johnson, L. V., Ozaki, S., Staples, M. K., Erickson, P. A. & Anderson, D. H. A potential role for immune complex pathogenesis in drusen formation. Exp Eye Res 70, 441\u2013449, https:\/\/doi.org\/10.1006\/exer.1999.0798 (2000).","journal-title":"Exp Eye Res"},{"key":"28143_CR13","doi-asserted-by":"publisher","first-page":"18","DOI":"10.3928\/23258160-20131217-01","volume":"45","author":"CA Garcia Filho","year":"2014","unstructured":"Garcia Filho, C. A. et al. Change in drusen volume as a novel clinical trial endpoint for the study of complement inhibition in age-related macular degeneration. Ophthalmic surgery, lasers & imaging retina 45, 18\u201331, https:\/\/doi.org\/10.3928\/23258160-20131217-01 (2014).","journal-title":"Ophthalmic surgery, lasers & imaging retina"},{"key":"28143_CR14","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.ophtha.2013.09.044","volume":"121","author":"Z Yehoshua","year":"2014","unstructured":"Yehoshua, Z. et al. Systemic complement inhibition with eculizumab for geographic atrophy in age-related macular degeneration: the COMPLETE study. Ophthalmology 121, 693\u2013701, https:\/\/doi.org\/10.1016\/j.ophtha.2013.09.044 (2014).","journal-title":"Ophthalmology"},{"key":"28143_CR15","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1167\/iovs.17-23134","volume":"59","author":"CB Toomey","year":"2018","unstructured":"Toomey, C. B. et al. Effect of Anti-C5a Therapy in a Murine Model of Early\/Intermediate Dry Age-Related Macular Degeneration. Invest Ophthalmol Vis Sci 59, 662\u2013673, https:\/\/doi.org\/10.1167\/iovs.17-23134 (2018).","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"28143_CR16","doi-asserted-by":"publisher","first-page":"2411","DOI":"10.1093\/hmg\/ddm198","volume":"16","author":"L Fu","year":"2007","unstructured":"Fu, L. et al. The R345W mutation in EFEMP1 is pathogenic and causes AMD-like deposits in mice. Hum Mol Genet 16, 2411\u20132422, https:\/\/doi.org\/10.1093\/hmg\/ddm198 (2007).","journal-title":"Hum Mol Genet"},{"key":"28143_CR17","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1093\/hmg\/ddt395","volume":"23","author":"DL Garland","year":"2013","unstructured":"Garland, D. L. et al. Mouse genetics and proteomic analyses demonstrate a critical role for complement in a model of DHRD\/ML, an inherited macular degeneration. Hum Mol Genet 23, 52\u201368, https:\/\/doi.org\/10.1093\/hmg\/ddt395 (2013).","journal-title":"Hum Mol Genet"},{"key":"28143_CR18","doi-asserted-by":"publisher","unstructured":"Fernandez-Godino, R., Bujakowska, K. M. & Pierce, E. A. Changes in extracellular matrix cause RPE cells to make basal deposits and activate the alternative complement pathway. Hum Mol Genet https:\/\/doi.org\/10.1093\/hmg\/ddx392 (2017).","DOI":"10.1093\/hmg\/ddx392"},{"key":"28143_CR19","doi-asserted-by":"publisher","first-page":"5555","DOI":"10.1093\/hmg\/ddv287","volume":"24","author":"R Fernandez-Godino","year":"2015","unstructured":"Fernandez-Godino, R., Garland, D. L. & Pierce, E. A. A local complement response by RPE causes early-stage macular degeneration. Hum Mol Genet 24, 5555\u20135569, https:\/\/doi.org\/10.1093\/hmg\/ddv287 (2015).","journal-title":"Hum Mol Genet"},{"key":"28143_CR20","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1093\/hmg\/ddt395","volume":"23","author":"DL Garland","year":"2014","unstructured":"Garland, D. L. et al. Mouse genetics and proteomic analyses demonstrate a critical role for complement in a model of DHRD\/ML, an inherited macular degeneration. Hum Mol Genet 23, 52\u201368, https:\/\/doi.org\/10.1093\/hmg\/ddt395 (2014).","journal-title":"Hum Mol Genet"},{"key":"28143_CR21","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1038\/ni.1923","volume":"11","author":"D Ricklin","year":"2010","unstructured":"Ricklin, D., Hajishengallis, G., Yang, K. & Lambris, J. D. Complement: a key system for immune surveillance and homeostasis. Nat Immunol 11, 785\u2013797, https:\/\/doi.org\/10.1038\/ni.1923 (2010).","journal-title":"Nat Immunol"},{"key":"28143_CR22","doi-asserted-by":"publisher","first-page":"2370","DOI":"10.1016\/j.molimm.2007.11.003","volume":"45","author":"F Bexborn","year":"2008","unstructured":"Bexborn, F., Andersson, P. O., Chen, H., Nilsson, B. & Ekdahl, K. N. The tick-over theory revisited: formation and regulation of the soluble alternative complement C3 convertase (C3(H2O)Bb. Mol Immunol 45, 2370\u20132379, https:\/\/doi.org\/10.1016\/j.molimm.2007.11.003 (2008).","journal-title":"Mol Immunol"},{"key":"28143_CR23","doi-asserted-by":"crossref","first-page":"2947","DOI":"10.4049\/jimmunol.160.6.2947","volume":"160","author":"H Hawlisch","year":"1998","unstructured":"Hawlisch, H. et al. Site-directed C3a receptor antibodies from phage display libraries. J Immunol 160, 2947\u20132958 (1998).","journal-title":"J Immunol"},{"key":"28143_CR24","doi-asserted-by":"publisher","first-page":"14534","DOI":"10.1074\/jbc.M114.564674","volume":"289","author":"K Kunchithapautham","year":"2014","unstructured":"Kunchithapautham, K., Atkinson, C. & Rohrer, B. Smoke exposure causes endoplasmic reticulum stress and lipid accumulation in retinal pigment epithelium through oxidative stress and complement activation. J Biol Chem 289, 14534\u201314546, https:\/\/doi.org\/10.1074\/jbc.M114.564674 (2014).","journal-title":"J Biol Chem"},{"key":"28143_CR25","doi-asserted-by":"publisher","first-page":"703","DOI":"10.3389\/fimmu.2017.00703","volume":"8","author":"C Busch","year":"2017","unstructured":"Busch, C. et al. Anaphylatoxins Activate Ca(2+), Akt\/PI3-Kinase, and FOXO1\/FoxP3 in the Retinal Pigment Epithelium. Front Immunol 8, 703, https:\/\/doi.org\/10.3389\/fimmu.2017.00703 (2017).","journal-title":"Front Immunol"},{"key":"28143_CR26","doi-asserted-by":"publisher","first-page":"2328","DOI":"10.1073\/pnas.0408835103","volume":"103","author":"M Nozaki","year":"2006","unstructured":"Nozaki, M. et al. Drusen complement components C3a and C5a promote choroidal neovascularization. Proc Natl Acad Sci USA 103, 2328\u20132333, https:\/\/doi.org\/10.1073\/pnas.0408835103 (2006).","journal-title":"Proc Natl Acad Sci USA"},{"key":"28143_CR27","doi-asserted-by":"publisher","first-page":"6489","DOI":"10.1167\/iovs.13-12374","volume":"54","author":"JE Ramos de Carvalho","year":"2013","unstructured":"Ramos de Carvalho, J. E. et al. Complement factor C3a alters proteasome function in human RPE cells and in an animal model of age-related RPE degeneration. Investigative ophthalmology & visual science 54, 6489\u20136501, https:\/\/doi.org\/10.1167\/iovs.13-12374 (2013).","journal-title":"Investigative ophthalmology & visual science"},{"key":"28143_CR28","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1006\/jmbi.2000.4185","volume":"303","author":"B Dahlmann","year":"2000","unstructured":"Dahlmann, B., Ruppert, T., Kuehn, L., Merforth, S. & Kloetzel, P. M. Different proteasome subtypes in a single tissue exhibit different enzymatic properties. J Mol Biol 303, 643\u2013653, https:\/\/doi.org\/10.1006\/jmbi.2000.4185 (2000).","journal-title":"J Mol Biol"},{"key":"28143_CR29","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1111\/j.1471-4159.2008.05345.x","volume":"106","author":"DA Ferrington","year":"2008","unstructured":"Ferrington, D. A. et al. Immunoproteasome responds to injury in the retina and brain. J Neurochem 106, 158\u2013169, https:\/\/doi.org\/10.1111\/j.1471-4159.2008.05345.x (2008).","journal-title":"J Neurochem"},{"key":"28143_CR30","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.exer.2006.12.002","volume":"84","author":"RJ Kapphahn","year":"2007","unstructured":"Kapphahn, R. J., Bigelow, E. J. & Ferrington, D. A. Age-dependent inhibition of proteasome chymotrypsin-like activity in the retina. Exp Eye Res 84, 646\u2013654, https:\/\/doi.org\/10.1016\/j.exer.2006.12.002 (2007).","journal-title":"Exp Eye Res"},{"key":"28143_CR31","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1007\/BF00941767","volume":"235","author":"KU Loeffler","year":"1997","unstructured":"Loeffler, K. U. & Mangini, N. J. Immunolocalization of ubiquitin and related enzymes in human retina and retinal pigment epithelium. Graefes Arch Clin Exp Ophthalmol 235, 248\u2013254 (1997).","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"28143_CR32","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.preteyeres.2015.09.002","volume":"51","author":"DA Ferrington","year":"2016","unstructured":"Ferrington, D. A., Sinha, D. & Kaarniranta, K. Defects in retinal pigment epithelial cell proteolysis and the pathology associated with age-related macular degeneration. Prog Retin Eye Res 51, 69\u201389, https:\/\/doi.org\/10.1016\/j.preteyeres.2015.09.002 (2016).","journal-title":"Prog Retin Eye Res"},{"key":"28143_CR33","doi-asserted-by":"publisher","first-page":"3622","DOI":"10.1167\/iovs.07-1559","volume":"49","author":"X Zhang","year":"2008","unstructured":"Zhang, X. et al. The proteasome: a target of oxidative damage in cultured human retina pigment epithelial cells. Invest Ophthalmol Vis Sci 49, 3622\u20133630, https:\/\/doi.org\/10.1167\/iovs.07-1559 (2008).","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"28143_CR34","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.2174\/156652412802480943","volume":"12","author":"SS Skandalis","year":"2012","unstructured":"Skandalis, S. S. et al. Targeting the tumor proteasome as a mechanism to control the synthesis and bioactivity of matrix macromolecules. Curr Mol Med 12, 1068\u20131082 (2012).","journal-title":"Curr Mol Med"},{"key":"28143_CR35","first-page":"1164","volume":"5","author":"MC Holland","year":"2004","unstructured":"Holland, M. C., Morikis, D. & Lambris, J. D. Synthetic small-molecule complement inhibitors. Curr Opin Investig Drugs 5, 1164\u20131173 (2004).","journal-title":"Curr Opin Investig Drugs"},{"key":"28143_CR36","doi-asserted-by":"publisher","first-page":"20231","DOI":"10.1074\/jbc.271.34.20231","volume":"271","author":"RS Ames","year":"1996","unstructured":"Ames, R. S. et al. Molecular cloning and characterization of the human anaphylatoxin C3a receptor. J Biol Chem 271, 20231\u201320234 (1996).","journal-title":"J Biol Chem"},{"key":"28143_CR37","doi-asserted-by":"publisher","first-page":"6341","DOI":"10.4049\/jimmunol.166.10.6341","volume":"166","author":"RS Ames","year":"2001","unstructured":"Ames, R. S. et al. Identification of a selective nonpeptide antagonist of the anaphylatoxin C3a receptor that demonstrates antiinflammatory activity in animal models. J Immunol 166, 6341\u20136348 (2001).","journal-title":"J Immunol"},{"key":"28143_CR38","doi-asserted-by":"publisher","first-page":"2071","DOI":"10.1182\/blood-2003-06-2099","volume":"103","author":"J Ratajczak","year":"2004","unstructured":"Ratajczak, J. et al. Mobilization studies in mice deficient in either C3 or C3a receptor (C3aR) reveal a novel role for complement in retention of hematopoietic stem\/progenitor cells in bone marrow. Blood 103, 2071\u20132078, https:\/\/doi.org\/10.1182\/blood-2003-06-2099 (2004).","journal-title":"Blood"},{"key":"28143_CR39","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1038\/sj.bjp.0705819","volume":"142","author":"LM Proctor","year":"2004","unstructured":"Proctor, L. M. et al. Comparative anti-inflammatory activities of antagonists to C3a and C5a receptors in a rat model of intestinal ischaemia\/reperfusion injury. Br J Pharmacol 142, 756\u2013764, https:\/\/doi.org\/10.1038\/sj.bjp.0705819 (2004).","journal-title":"Br J Pharmacol"},{"key":"28143_CR40","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1254\/jphs.09180FP","volume":"112","author":"P Hutamekalin","year":"2010","unstructured":"Hutamekalin, P. et al. Effect of the C3a-receptor antagonist SB 290157 on anti-OVA polyclonal antibody-induced arthritis. Journal of pharmacological sciences 112, 56\u201363 (2010).","journal-title":"Journal of pharmacological sciences"},{"key":"28143_CR41","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/j.1432-1033.1993.tb18245.x","volume":"217","author":"J Norgauer","year":"1993","unstructured":"Norgauer, J. et al. Complement fragment C3a stimulates Ca2+ influx in neutrophils via a pertussis-toxin-sensitive G protein. Eur J Biochem 217, 289\u2013294 (1993).","journal-title":"Eur J Biochem"},{"key":"28143_CR42","doi-asserted-by":"publisher","first-page":"3012","DOI":"10.1167\/iovs.13-13554","volume":"55","author":"P Yang","year":"2014","unstructured":"Yang, P. et al. Retinal pigment epithelial cell death by the alternative complement cascade: role of membrane regulatory proteins, calcium, PKC, and oxidative stress. Invest Ophthalmol Vis Sci 55, 3012\u20133021, https:\/\/doi.org\/10.1167\/iovs.13-13554 (2014).","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"28143_CR43","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1016\/j.chembiol.2006.09.013","volume":"13","author":"M Verdoes","year":"2006","unstructured":"Verdoes, M. et al. A fluorescent broad-spectrum proteasome inhibitor for labeling proteasomes in vitro and in vivo. Chem Biol 13, 1217\u20131226, https:\/\/doi.org\/10.1016\/j.chembiol.2006.09.013 (2006).","journal-title":"Chem Biol"},{"key":"28143_CR44","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/S1074-5521(01)00056-4","volume":"8","author":"AF Kisselev","year":"2001","unstructured":"Kisselev, A. F. & Goldberg, A. L. Proteasome inhibitors: from research tools to drug candidates. Chem Biol 8, 739\u2013758 (2001).","journal-title":"Chem Biol"},{"key":"28143_CR45","doi-asserted-by":"publisher","first-page":"2336","DOI":"10.1096\/fj.201500044","volume":"30","author":"H Gu","year":"2016","unstructured":"Gu, H. et al. Contribution of the anaphylatoxin receptors, C3aR and C5aR, to the pathogenesis of pulmonary fibrosis. FASEB J 30, 2336\u20132350, https:\/\/doi.org\/10.1096\/fj.201500044 (2016).","journal-title":"FASEB J"},{"key":"28143_CR46","doi-asserted-by":"publisher","first-page":"e113639","DOI":"10.1371\/journal.pone.0113639","volume":"9","author":"L Li","year":"2014","unstructured":"Li, L. et al. C3a receptor antagonist ameliorates inflammatory and fibrotic signals in type 2 diabetic nephropathy by suppressing the activation of TGF-beta\/smad3 and IKBalpha pathway. PLoS One 9, e113639, https:\/\/doi.org\/10.1371\/journal.pone.0113639 (2014).","journal-title":"PLoS One"},{"key":"28143_CR47","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/S0945-053X(00)00132-3","volume":"20","author":"E Reale","year":"2001","unstructured":"Reale, E., Groos, S., Luciano, L., Eckardt, C. & Eckardt, U. In the mammalian eye type VI collagen tetramers form three morphologically different aggregates. Matrix Biol 20, 37\u201351 (2001).","journal-title":"Matrix Biol"},{"key":"28143_CR48","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/S1047-8477(02)00534-8","volume":"139","author":"C Knupp","year":"2002","unstructured":"Knupp, C., Amin, S. Z., Munro, P. M., Luthert, P. J. & Squire, J. M. Collagen VI assemblies in age-related macular degeneration. J Struct Biol 139, 181\u2013189 (2002).","journal-title":"J Struct Biol"},{"key":"28143_CR49","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/j.ceb.2009.06.006","volume":"21","author":"CJ Morrison","year":"2009","unstructured":"Morrison, C. J., Butler, G. S., Rodriguez, D. & Overall, C. M. Matrix metalloproteinase proteomics: substrates, targets, and therapy. Curr Opin Cell Biol 21, 645\u2013653, https:\/\/doi.org\/10.1016\/j.ceb.2009.06.006 (2009).","journal-title":"Curr Opin Cell Biol"},{"key":"28143_CR50","first-page":"3743","volume":"58","author":"EI Deryugina","year":"1998","unstructured":"Deryugina, E. I., Bourdon, M. A., Reisfeld, R. A. & Strongin, A. Remodeling of collagen matrix by human tumor cells requires activation and cell surface association of matrix metalloproteinase-2. Cancer Res 58, 3743\u20133750 (1998).","journal-title":"Cancer Res"},{"key":"28143_CR51","doi-asserted-by":"publisher","first-page":"3331","DOI":"10.1167\/iovs.04-1224","volume":"46","author":"Marin-Castano","year":"2005","unstructured":"Marin-Castano. Nonlethal Oxidant Injury to Human Retinal Pigment Epithelium Cells Causes Cell Membrane Blebbing but Decreased MMP-2 Activity. Investigative ophthalmology & visual science 46, 3331\u20133340 (2005).","journal-title":"Investigative ophthalmology & visual science"},{"key":"28143_CR52","first-page":"2676","volume":"40","author":"L Guo","year":"1999","unstructured":"Guo, L., Hussain, A. A., Limb, G. A. & Marshall, J. Age-dependent variation in metalloproteinase activity of isolated human Bruch\u2019s membrane and choroid. Investigative ophthalmology & visual science 40, 2676\u20132682 (1999).","journal-title":"Investigative ophthalmology & visual science"},{"key":"28143_CR53","doi-asserted-by":"publisher","first-page":"230805","DOI":"10.1155\/2013\/230805","volume":"2013","author":"SA Syggelos","year":"2013","unstructured":"Syggelos, S. A., Aletras, A. J., Smirlaki, I. & Skandalis, S. S. Extracellular matrix degradation and tissue remodeling in periprosthetic loosening and osteolysis: focus on matrix metalloproteinases, their endogenous tissue inhibitors, and the proteasome. Biomed Res Int 2013, 230805, https:\/\/doi.org\/10.1155\/2013\/230805 (2013).","journal-title":"Biomed Res Int"},{"key":"28143_CR54","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1126\/science.1087753","volume":"302","author":"TM Dawson","year":"2003","unstructured":"Dawson, T. M. & Dawson, V. L. Molecular pathways of neurodegeneration in Parkinson\u2019s disease. Science 302, 819\u2013822, https:\/\/doi.org\/10.1126\/science.1087753 (2003).","journal-title":"Science"},{"key":"28143_CR55","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1046\/j.1471-4159.2003.01844.x","volume":"86","author":"AD Hope","year":"2003","unstructured":"Hope, A. D. et al. Alzheimer\u2019s associated variant ubiquitin causes inhibition of the 26S proteasome and chaperone expression. J Neurochem 86, 394\u2013404 (2003).","journal-title":"J Neurochem"},{"key":"28143_CR56","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.mam.2012.04.001","volume":"33","author":"F Shang","year":"2012","unstructured":"Shang, F. & Taylor, A. Roles for the ubiquitin-proteasome pathway in protein quality control and signaling in the retina: implications in the pathogenesis of age-related macular degeneration. Mol Aspects Med 33, 446\u2013466, https:\/\/doi.org\/10.1016\/j.mam.2012.04.001 (2012).","journal-title":"Mol Aspects Med"},{"key":"28143_CR57","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1194\/jlr.R002238","volume":"51","author":"CA Curcio","year":"2010","unstructured":"Curcio, C. A., Johnson, M., Huang, J. D. & Rudolf, M. Apolipoprotein B-containing lipoproteins in retinal aging and age-related macular degeneration. J Lipid Res 51, 451\u2013467, https:\/\/doi.org\/10.1194\/jlr.R002238 (2010).","journal-title":"J Lipid Res"},{"key":"28143_CR58","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/S0002-9440(10)63836-9","volume":"162","author":"G Malek","year":"2003","unstructured":"Malek, G., Li, C. M., Guidry, C., Medeiros, N. E. & Curcio, C. A. Apolipoprotein B in cholesterol-containing drusen and basal deposits of human eyes with age-related maculopathy. Am J Pathol 162, 413\u2013425, https:\/\/doi.org\/10.1016\/S0002-9440(10)63836-9 (2003).","journal-title":"Am J Pathol"},{"key":"28143_CR59","doi-asserted-by":"publisher","first-page":"14682","DOI":"10.1073\/pnas.222551899","volume":"99","author":"JW Crabb","year":"2002","unstructured":"Crabb, J. W. et al. Drusen proteome analysis: an approach to the etiology of age-related macular degeneration. Proc Natl Acad Sci USA 99, 14682\u201314687, https:\/\/doi.org\/10.1073\/pnas.222551899 (2002).","journal-title":"Proc Natl Acad Sci USA"},{"key":"28143_CR60","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1096\/fj.12-220582","volume":"27","author":"J Lim","year":"2013","unstructured":"Lim, J. et al. C5aR and C3aR antagonists each inhibit diet-induced obesity, metabolic dysfunction, and adipocyte and macrophage signaling. FASEB J 27, 822\u2013831, https:\/\/doi.org\/10.1096\/fj.12-220582 (2013).","journal-title":"FASEB J"},{"key":"28143_CR61","doi-asserted-by":"publisher","first-page":"11830","DOI":"10.1073\/pnas.192203399","volume":"99","author":"LV Johnson","year":"2002","unstructured":"Johnson, L. V. et al. The Alzheimer\u2019s A beta -peptide is deposited at sites of complement activation in pathologic deposits associated with aging and age-related macular degeneration. Proc Natl Acad Sci USA 99, 11830\u201311835, https:\/\/doi.org\/10.1073\/pnas.192203399 (2002).","journal-title":"Proc Natl Acad Sci USA"},{"key":"28143_CR62","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.neuron.2014.11.018","volume":"85","author":"H Lian","year":"2015","unstructured":"Lian, H. et al. NFkappaB-activated astroglial release of complement C3 compromises neuronal morphology and function associated with Alzheimer\u2019s disease. Neuron 85, 101\u2013115, https:\/\/doi.org\/10.1016\/j.neuron.2014.11.018 (2015).","journal-title":"Neuron"},{"key":"28143_CR63","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-00414-w","volume":"8","author":"RJ Lohman","year":"2017","unstructured":"Lohman, R. J. et al. Exploiting a novel conformational switch to control innate immunity mediated by complement protein C3a. Nat Commun 8, 351, https:\/\/doi.org\/10.1038\/s41467-017-00414-w (2017).","journal-title":"Nat Commun"},{"key":"28143_CR64","doi-asserted-by":"publisher","first-page":"3612","DOI":"10.1167\/iovs.05-1622","volume":"47","author":"A Maminishkis","year":"2006","unstructured":"Maminishkis, A. et al. Confluent monolayers of cultured human fetal retinal pigment epithelium exhibit morphology and physiology of native tissue. Invest Ophthalmol Vis Sci 47, 3612\u20133624, https:\/\/doi.org\/10.1167\/iovs.05-1622 (2006).","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"28143_CR65","doi-asserted-by":"publisher","unstructured":"Maminishkis, A. & Miller, S. S. Experimental models for study of retinal pigment epithelial physiology and pathophysiology. J Vis Exp https:\/\/doi.org\/10.3791\/2032 (2010).","DOI":"10.3791\/2032"},{"key":"28143_CR66","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1038\/nprot.2016.065","volume":"11","author":"R Fernandez-Godino","year":"2016","unstructured":"Fernandez-Godino, R., Garland, D. L. & Pierce, E. A. Isolation, culture and characterization of primary mouse RPE cells. Nat Protoc 11, 1206\u20131218, https:\/\/doi.org\/10.1038\/nprot.2016.065 (2016).","journal-title":"Nat Protoc"},{"key":"28143_CR67","doi-asserted-by":"publisher","first-page":"6341","DOI":"10.4049\/jimmunol.166.10.6341","volume":"166","author":"RS Ames","year":"2001","unstructured":"Ames, R. S. et al. Identification of a selective nonpeptide antagonist of the anaphylatoxin C3a receptor that demonstrates antiinflammatory activity in animal models. J Immunol 166, 6341\u20136348 (2001).","journal-title":"J Immunol"},{"key":"28143_CR68","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/nmeth.2089","volume":"9","author":"CA Schneider","year":"2012","unstructured":"Schneider, C. A., Rasband, W. S. & Eliceiri, K. W. NIH Image to ImageJ: 25 years of image analysis. Nat Methods 9, 671\u2013675 (2012).","journal-title":"Nat Methods"},{"key":"28143_CR69","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1038\/nprot.2013.065","volume":"8","author":"N Li","year":"2013","unstructured":"Li, N. et al. Relative quantification of proteasome activity by activity-based protein profiling and LC-MS\/MS. Nat Protoc 8, 1155\u20131168, https:\/\/doi.org\/10.1038\/nprot.2013.065 (2013).","journal-title":"Nat Protoc"},{"key":"28143_CR70","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/978-1-4939-6439-0_15","volume":"1491","author":"GP Soriano","year":"2017","unstructured":"Soriano, G. P., Overkleeft, H. S. & Florea, B. I. Two-Step Activity-Based Protein Profiling with the Proteasome System as Model of Study. Methods Mol Biol 1491, 205\u2013215, https:\/\/doi.org\/10.1007\/978-1-4939-6439-0_15 (2017).","journal-title":"Methods Mol Biol"},{"key":"28143_CR71","doi-asserted-by":"publisher","first-page":"4199","DOI":"10.1002\/anie.201509092","volume":"55","author":"G de Bruin","year":"2016","unstructured":"de Bruin, G. et al. A Set of Activity-Based Probes to Visualize Human (Immuno)proteasome Activities. Angew Chem Int Ed Engl 55, 4199\u20134203, https:\/\/doi.org\/10.1002\/anie.201509092 (2016).","journal-title":"Angew Chem Int Ed Engl"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-28143-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-28143-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-28143-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,3]],"date-time":"2023-09-03T03:53:13Z","timestamp":1693713193000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-28143-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,26]]},"references-count":71,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["28143"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-28143-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,26]]},"assertion":[{"value":"10 February 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"9679"}}